Your browser is no longer supported. Please, upgrade your browser.
Settings
SRRA Sierra Oncology, Inc. daily Stock Chart
SRRA [NASD]
Sierra Oncology, Inc.
Index- P/E- EPS (ttm)-19.47 Insider Own0.10% Shs Outstand10.40M Perf Week4.17%
Market Cap131.45M Forward P/E- EPS next Y-5.99 Insider Trans- Shs Float9.97M Perf Month20.85%
Income-108.70M PEG- EPS next Q-1.64 Inst Own79.50% Short Float0.10% Perf Quarter-2.45%
Sales- P/S- EPS this Y-0.50% Inst Trans- Short Ratio0.42 Perf Half Y7.96%
Book/sh11.22 P/B1.14 EPS next Y21.60% ROA-89.40% Target Price- Perf Year8.42%
Cash/sh11.95 P/C1.07 EPS next 5Y- ROE-111.10% 52W Range8.55 - 22.00 Perf YTD-6.91%
Dividend- P/FCF- EPS past 5Y-7.90% ROI- 52W High-42.05% Beta1.53
Dividend %- Quick Ratio13.90 Sales past 5Y- Gross Margin- 52W Low49.21% ATR0.50
Employees71 Current Ratio13.90 Sales Q/Q- Oper. Margin- RSI (14)65.25 Volatility3.45% 4.29%
OptionableNo Debt/Eq0.00 EPS Q/Q80.10% Profit Margin- Rel Volume0.32 Prev Close12.42
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume22.87K Price12.75
Recom1.50 SMA2011.59% SMA509.55% SMA2003.42% Volume7,385 Change2.66%
Jul-30-20Initiated H.C. Wainwright Buy $20
Dec-06-19Initiated Oppenheimer Outperform $1.20
Oct-23-17Upgrade Jefferies Hold → Buy
Mar-10-17Upgrade SunTrust Hold → Buy
Feb-22-17Resumed Wedbush Outperform $3 → $4
Oct-02-20 07:00AM  
07:00AM  
Sep-14-20 07:00AM  
07:00AM  
Sep-04-20 03:47PM  
Aug-06-20 07:05AM  
07:00AM  
Jul-28-20 07:00AM  
Jun-26-20 11:44AM  
Jun-18-20 12:00PM  
Jun-16-20 04:05PM  
Jun-12-20 02:30AM  
02:30AM  
May-27-20 07:00AM  
07:00AM  
May-26-20 07:00AM  
07:00AM  
May-14-20 09:00AM  
May-07-20 08:00AM  
08:00AM  
07:00AM  
May-04-20 12:45PM  
Apr-21-20 05:31PM  
Mar-03-20 07:00AM  
Feb-26-20 08:47AM  
07:00AM  
Feb-25-20 07:00AM  
Feb-11-20 07:23AM  
Feb-06-20 07:00AM  
Jan-28-20 07:09AM  
Jan-22-20 07:00AM  
Jan-06-20 02:17PM  
Dec-19-19 06:08PM  
Dec-07-19 09:00AM  
09:00AM  
Dec-02-19 07:00AM  
Nov-26-19 07:00AM  
Nov-20-19 07:00AM  
Nov-14-19 04:05PM  
04:05PM  
Nov-07-19 09:02AM  
09:01AM  
09:01AM  
Nov-06-19 04:01PM  
04:01PM  
09:00AM  
Nov-04-19 04:01PM  
04:01PM  
Sep-13-19 12:00PM  
Aug-08-19 07:00AM  
Aug-07-19 07:00AM  
Jul-15-19 03:03PM  
Jun-29-19 11:33PM  
Jun-27-19 07:00AM  
07:00AM  
Jun-05-19 06:00AM  
06:00AM  
Jun-04-19 05:04PM  
05:04PM  
Jun-03-19 07:00AM  
07:00AM  
Jun-01-19 09:00AM  
May-28-19 07:00AM  
07:00AM  
May-15-19 05:00PM  
May-08-19 07:53AM  
07:00AM  
07:00AM  
May-06-19 07:00AM  
Apr-26-19 11:55AM  
Apr-03-19 08:00AM  
Apr-01-19 04:05PM  
04:05PM  
Mar-05-19 07:00AM  
Feb-28-19 07:00AM  
Feb-27-19 04:30PM  
Jan-23-19 07:00AM  
Jan-22-19 10:24AM  
Dec-03-18 07:00AM  
07:00AM  
Nov-29-18 05:00PM  
Nov-27-18 05:00PM  
Nov-22-18 12:11PM  
Nov-15-18 05:00AM  
Nov-13-18 07:00AM  
Nov-08-18 07:00AM  
Nov-07-18 07:00AM  
Nov-01-18 09:20AM  
Oct-04-18 07:00AM  
Aug-30-18 07:24AM  
Aug-22-18 05:32PM  
07:05AM  
07:00AM  
Aug-09-18 07:00AM  
Aug-07-18 07:00AM  
Jul-23-18 07:05AM  
Jul-19-18 05:57AM  
Jun-26-18 07:15AM  
Jun-01-18 09:42AM  
May-25-18 07:10AM  
Sierra Oncology, Inc. researches, develops, and commercializes therapies for the treatment of patients with hematology and oncology needs. Its lead drug candidate, momelotinib, is a selective and orally-bioavailable JAK1, JAK2, and ACVR1 inhibitor that has been investigated in two completed Phase 3 trials for the treatment of myelofibrosis. The company is also advancing SRA737, an orally bioavailable small molecule inhibitor Checkpoint kinase 1 is being investigated in two Phase 1/2 clinical trials; and SRA141, an orally bioavailable small molecule inhibitor of cell division cycle 7 kinase. The company was formerly known as ProNAi Therapeutics, Inc. and changed its name to Sierra Oncology, Inc. in January 2017. Sierra Oncology, Inc. was founded in 2003 and is headquartered in Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Klencke BarbaraChief Development OfficerAug 18Buy12.253,32540,7385,000Aug 18 08:16 PM
Klencke BarbaraChief Development OfficerAug 18Buy12.225,95072,71010,000Aug 18 08:16 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.